Stock listing
A3CRY2 Stock Price, News, Filings & Events — Arecor Therapeutics Plc
Selected listing: A3CRY2 · LS · EUR · DE
This page tracks Arecor Therapeutics Plc's A3CRY2:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3CRY2:LS. A3CRY2:LS is the stock-level entry point for investors researching Arecor Therapeutics Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3CRY2:LS
- Asset type
- Stock
- Market cap
- $35.2M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LS
- Currency
- EUR
Arecor Therapeutics Plc A3CRY2:LS stock context
This page tracks Arecor Therapeutics Plc's A3CRY2:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3CRY2:LS. A3CRY2:LS is the stock-level entry point for investors researching Arecor Therapeutics Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Arecor Therapeutics Plc
Arecor Therapeutics Plc earnings calls
Arecor Therapeutics plc (AREC) Q4 2025 Earnings Call
April 23, 2026 · Replay with transcript and chapters
ARECOR THERAPEUTICS PLC (AREC) — Arecor Interim Results, Co-development Agreement & Sale of Royalty and Technology Access Fees
October 2, 2025 · Replay with transcript and chapters
ARECOR THERAPEUTICS PLC (AREC) — Final Results Results for the year ended 31 December 2024
May 1, 2025 · Replay with transcript and chapters
ARECOR THERAPEUTICS PLC (AREC) — Interim Results
October 3, 2024 · Replay with transcript and chapters
ARECOR THERAPEUTICS PLC (AREC) — Investor Presentation
September 20, 2023 · Replay with transcript and chapters
ARECOR THERAPEUTICS PLC (AREC) — Results
April 26, 2023 · Replay with transcript and chapters
Research Arecor Therapeutics Plc
Arecor Therapeutics Plc investor report
Review AI stock analysis and investor report context for A3CRY2:LS.
Arecor Therapeutics Plc company profile
View the public company page for Arecor Therapeutics Plc on 6ix.
Arecor Therapeutics Plc news
Read company news and market updates connected to Arecor Therapeutics Plc.
Arecor Therapeutics Plc investor events
Find investor webinars, events, and replay context for Arecor Therapeutics Plc.
Alternate listings
AREC:LSE
GB · GBX
Alternate listing for Arecor Therapeutics Plc; the primary context on this page is A3CRY2:LS.
A3CRY2:LSX
DE · EUR
Alternate listing for Arecor Therapeutics Plc; the primary context on this page is A3CRY2:LS.
6UI:DUS
DE · EUR
Alternate listing for Arecor Therapeutics Plc; the primary context on this page is A3CRY2:LS.
6UI:SWB
DE · EUR
Alternate listing for Arecor Therapeutics Plc; the primary context on this page is A3CRY2:LS.
6UI:FWB
DE · EUR
Alternate listing for Arecor Therapeutics Plc; the primary context on this page is A3CRY2:LS.